Article info
Correspondence
Menopause and hormone therapy in the 21st century: why promote transdermal estradiol and progesterone?
- Correspondence to Professor Pierre-Yves Scarabin, Center for Research in Epidemiology and Population Health, INSERM, Villejuif 69372, France; pierre-yves.scarabin{at}inserm.fr
Citation
Menopause and hormone therapy in the 21st century: why promote transdermal estradiol and progesterone?
Publication history
- First published May 22, 2020.
Online issue publication
July 27, 2020
Article Versions
- Previous version (22 May 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.